LY3192767: Clinical Trials

1 trial of LY3192767, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow LY3192767: new trials by email Literature Review of LY3192767 trials Research Report on LY3192767

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of LY3192767 in Healthy Participants
LY3192767, Basal Insulin Peglispro, Insulin Glargine - Healthy
Phase 1CompletedEli Lilly and Company572017-03-062019-04-05

Sponsors

Eli Lilly and Company (1)

Countries

Germany (1)

NIH funding

2016 (1)